We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

603659:SSEShanghai Putailai New Energy Technology Co., Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥30.77

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shanghai Putailai New Energy Technology Group is trading at CNY 30.77, comfortably above its 20‑day (CNY 28.91) and 200‑day (CNY 24.13) simple moving averages, and the MACD line sits in bullish territory (0.73 vs signal 0.34). The RSI of 59 signals moderate upward momentum while volume is on an increasing trend, suggesting short‑term buying pressure. However, the stock’s forward PE of 20.8 and trailing PE of 28.8 are well above the DCF‑derived fair value of CNY 18, indicating the market is pricing in a premium that may be hard to sustain. Revenue is growing at a robust 35% YoY and the company delivers a 12.6% ROE, but a debt‑to‑equity ratio of 48% and a high 46% 30‑day volatility raise concerns about financial leverage and price swings. Dividend sustainability looks solid with a modest 0.53% yield and a low 15% payout ratio backed by positive operating cash flow.
Overall, the stock benefits from strong sector tailwinds in lithium‑ion battery materials, but the current valuation gap and elevated volatility suggest a cautious stance, balancing bullish technicals against overvaluation and leverage risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical setup (price above SMAs, MACD bullish)
  • Significant valuation premium vs DCF fair value
  • High short‑term volatility (~46%)

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth (35% YoY) and EV battery tailwinds
  • Improving forward PE (20.8) relative to peers
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term demand for lithium‑ion battery materials
  • Solid ROE (12.6%) and positive free cash flow
  • Leverage level (Debt/Equity 48%) and valuation gap remain considerations

Key Metrics & Analysis

Financial Health

Revenue Growth35.30%
Profit Margin15.02%
P/E Ratio28.8
ROE12.61%
ROA4.05%
Debt/Equity47.86
P/B Ratio3.2
Op. Cash FlowCN¥2.7B
Free Cash FlowCN¥1.1B

Technical Analysis

TrendBullish
RSI59.2
SupportCN¥25.35
ResistanceCN¥33.25
MA 20CN¥28.91
MA 50CN¥28.35
MA 200CN¥24.13
MACDBullish
VolumeIncreasing
Fear & Greed Index81.41

Valuation

Fair ValueCN¥17.99
GradeOvervalued
TypeBlend
Dividend Yield0.53%

Risk Assessment

Beta0.09
Volatility46.15%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.